熱點掃描 | 港股汽車股走低
uSMART盈立智投11月3日消息,截止發稿,港股三大指數齊跌,恆生指數跌0.25%報25038.13點,成交額290.09億;恆生科技指數跌0.48%報6284.18點,成交額57.77億;紅籌指數跌0.30%報3778.53點,成交額5.12億。
板塊方面:
港股汽車股走低,理想汽車、小鵬汽車跌近3%,比亞迪股份跌1.81%,北京汽車跌1.49%。
港股內房股普遍走高,佳兆業集團漲5.66%,融創中國漲3.49%,中國恆大漲1.71%,碧桂園漲1.38%。
港股光伏太陽能板塊多數下跌,信義光能跌7.68%,信義能源、保利協鑫能源、福萊特玻璃均跌超5%,福耀玻璃跌1.97%。
個股方面:
融信中國漲5.03%,前10個月總合約銷售額1355.33億元,同比增18%。
合生創展集團漲1.98%,10月總合約銷售金額約61.36億元,同比上升77%。
譚仔國際漲超12%創上市新高,近日獲國泰君安增持涉資約1.29億港元。
中糧家佳康漲超5%,機構稱生豬開啓周度探底後反彈行情。
信義系早盤集體重挫,信義光能、信義能源均跌超7%。
李寧漲超6%,第三季度零售增長範圍超出裏昂預期,該行予其“買入”評級並升目標價至117港元。
藥明生物早盤高開2.68%領漲藍籌,截至9月底公司CMO項目總數已達6個,獲高盛升目標價至178.6港元。
金斯瑞生物科技高開逾5%,美國FDA延長西達基奧侖賽的處方藥使用者費用法案目標日期。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.